Code of Federal Regulations · Subpart

Subpart G — Tumor Associated Antigen Immunological Test Systems

21 C.F.R. pt. 866, subpt. G

• § 866.6000 Whole Exome Sequencing Constituent Device
• § 866.6010 Tumor-associated Antigen Immunological Test System
• § 866.6020 Immunomagnetic Circulating Cancer Cell Selection And Enumeration System
• § 866.6030 Afp-l3% Immunological Test System
• § 866.6040 Gene Expression Profiling Test System For Breast Cancer Prognosis
• § 866.6050 Ovarian Adnexal Mass Assessment Score Test System
• § 866.6060 Bcr-abl Quantitation Test
• § 866.6070 Mutation Detection Test For Myeloproliferative Neoplasms
• § 866.6080 Next Generation Sequencing Based Tumor Profiling Test
• § 866.6090 Cancer Predisposition Risk Assessment System
• § 866.6100 Dna-based Test To Measure Minimal Residual Disease In Hematological Malignancies